Jerri M. Rook

2.3k citations

56 papers · 1.6k indexed · h-index 25

Impact in

Cellular and Molecular Neuroscience top 1%
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
- Neurotransmitter Receptor Influence on Behavior
Biological Psychiatry top 10%

Papers in

Cellular and Molecular Neuroscience 40
- Neuroscience and Neuropharmacology Research 36
- Neuropeptides and Animal Physiology 5
- Neurotransmitter Receptor Influence on Behavior 4
Molecular Biology 44
- Receptor Mechanisms and Signaling 40
- Ion channel regulation and function 13
- Nicotinic Acetylcholine Receptors Study 10
- Pharmacological Receptor Mechanisms and Effects 6

Co-authors: P. Jeffrey Conn Craig W. Lindsley Colleen M. Niswender Carrie K. Jones Kenneth E. McCarson Zixiu Xiang Shaun R. Stauffer Wohaib Hasan
Journals: ACS Chemical Neuroscience (8 papers)Neuropsychopharmacology (7 papers)Molecular Pharmacology (4 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
Partner nations: United States Australia Denmark

In The Last Decade

Jerri M. Rook

54 papers receiving 1.6k citations

Peers

Countries citing papers authored by Jerri M. Rook

Since Specialization

Citations

This map shows the geographic impact of Jerri M. Rook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerri M. Rook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerri M. Rook more than expected).

Fields of papers citing papers by Jerri M. Rook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerri M. Rook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerri M. Rook. The network helps show where Jerri M. Rook may publish in the future.

Co-authors

The 25 scholars most cited alongside Jerri M. Rook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jerri M. Rook Line = papers co-authored together Jerri M. Rook links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Application of Deuterium in an M₁ Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422 ACS Chemical Neuroscience ·Julie L. Engers, Jinming Li, Changho Han, Madeline F. Long, Alison R. Gregro, Christopher C. Presley, Jonathan W. Dickerson, Weimin Peng, Hyekyung P. Cho, Alice L. Rodriguez, Zixiu Xiang, Olivier Boutaud, C. O’Carroll, Prabuddha Dey, Ethan S. Burstein, Colleen M. Niswender, Jerri M. Rook, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley	2025	0
2	Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) ACS Chemical Neuroscience ·Julie L. Engers, Logan A. Baker, Sichen Chang, Vincent B. Luscombe, Alice L. Rodriguez, Colleen M. Niswender, Hyekyung P. Cho, Michael Bubser, Analisa Thompson Gray, Carrie K. Jones, Weimin Peng, Jerri M. Rook, Thomas M. Bridges, Olivier Boutaud, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley, Kayla J. Temple	2024	1
3	M1 Positive Allosteric Modulators Enhance Domains of Cognitive Function by Activation of ssT-expressing Interneurons in the Prefrontal Cortex Journal of Pharmacology and Experimental Therapeutics ·Jerri M. Rook, Zixiu Xiang, Jonathan W. Dickerson, Shalini Dogra, Kendall Jensen, In-Sung Kim, Megan Ohler, Kelly Weiss, P. Jeffrey Conn	2023	1
4	Development of a Selective and High Affinity Radioligand, [3H]VU6013720, for the M4 Muscarinic Receptor Molecular Pharmacology ·Aidong Qi, Haley E. Kling, Natasha B. Billard, Alice L. Rodriguez, Peng Li, Jonathan W. Dickerson, Julie L. Engers, Aaron M. Bender, Mark S. Moehle, Craig W. Lindsley, Jerri M. Rook, Colleen M. Niswender	2023	2
5	Biased M ₁ receptor–positive allosteric modulators reveal role of phospholipase D in M ₁ -dependent rodent cortical plasticity Science Signaling ·Sean P. Moran, Zixiu Xiang, Catherine A. Doyle, James Maksymetz, Xiaohui Lv, Sehr Faltin, Nicole M. Fisher, Aaron M. Bender, Colleen M. Niswender, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn	2019	8
6	A Novel M ₁ PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity ACS Chemical Neuroscience ·Jerri M. Rook, Jeanette L. Bertron, Hyekyung P. Cho, Pedro M. García-Barrantes, Sean P. Moran, James Maksymetz, Kellie D. Nance, Jonathan W. Dickerson, Daniel H. Remke, Sichen Chang, Joel M. Harp, Anna L. Blobaum, Colleen M. Niswender, Carrie K. Jones, Shaun R. Stauffer, P. Jeffrey Conn, Craig W. Lindsley	2018	45
7	M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition Neuropsychopharmacology ·Sean P. Moran, Jonathan W. Dickerson, Hyekyung P. Cho, Zixiu Xiang, James Maksymetz, Daniel H. Remke, Xiaohui Lv, Catherine A. Doyle, Deepa Rajan, Colleen M. Niswender, Darren W. Engers, Craig W. Lindsley, Jerri M. Rook, P. Jeffrey Conn	2018	58
8	PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems ACS Chemical Neuroscience ·Sean P. Moran, Hyekyung P. Cho, James Maksymetz, Daniel H. Remke, Ryan Hanson, Colleen M. Niswender, Craig W. Lindsley, Jerri M. Rook, P. Jeffrey Conn	2018	18
9	Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation Neuropsychopharmacology ·Adam G. Walker, Douglas J. Sheffler, Andrew Lewis, Jonathan W. Dickerson, Daniel J. Foster, Rebecca K. Senter, Mark S. Moehle, Xiaohui Lv, Branden J. Stansley, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Craig W. Lindsley, P. Jeffrey Conn	2017	16
10	M 1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons Neuropharmacology ·Xiaohui Lv, Jonathan W. Dickerson, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn, Zixiu Xiang	2017	29
11	Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor Neuron ·Mark S. Moehle, Tristano Pancani, Nellie Byun, Samantha E. Yohn, George H. Wilson, Johnathan W. Dickerson, Daniel H. Remke, Zixiu Xiang, Colleen M. Niswender, Jürgen Wess, Carrie K. Jones, Craig W. Lindsley, Jerri M. Rook, P. Jeffrey Conn	2017	44
12	mGlu₅positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome Human Molecular Genetics ·Rocco G. Gogliotti, Rebecca K. Senter, Jerri M. Rook, Ayan Ghoshal, Rocio Zamorano, Chrysa Malosh, Shaun R. Stauffer, Thomas M. Bridges, José M. Bartolomé, J. Scott Daniels, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender	2016	49
13	An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia Neuropsychopharmacology ·Darrick T. Balu, Yan Li, Shunsuke Takagi, Kendall Taylor Presti, Teniel S Ramikie, Jerri M. Rook, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Vadim Y. Bolshakov, Joseph T. Coyle	2016	52
14	Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model Neuropsychopharmacology ·Ayan Ghoshal, Jerri M. Rook, Jonathan W. Dickerson, G N Roop, Ryan D. Morrison, Nidhi Jalan‐Sakrikar, Atin Lamsal, Meredith J. Noetzel, Michael S. Poslusney, Michael R. Wood, Bruce J. Melancon, Shaun R. Stauffer, Zixiu Xiang, J. Scott Daniels, Colleen M. Niswender, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn	2015	81
15	Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects Neuropsychopharmacology ·Robert W. Gould, Russell J. Amato, Michael Bubser, Max E. Joffe, Michael T. Nedelcovych, Analisa D. Thompson, Hilary Highfield Nickols, Johannes P Yuh, Xiaoyan Zhan, Andrew S. Felts, Alice L. Rodriguez, Ryan D. Morrison, Frank W. Byers, Jerri M. Rook, J. Scott Daniels, Colleen M. Niswender, P. Jeffrey Conn, Kyle A. Emmitte, Craig W. Lindsley, Carrie K. Jones	2015	36
16	Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction Proceedings of the National Academy of Sciences ·Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn	2015	78
17	Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles Neuropsychopharmacology ·Jerri M. Rook, Mohammed Noor Tantawy, M. Sib Ansari, Andrew S. Felts, Shaun R. Stauffer, Kyle A. Emmitte, Robert Kessler, Colleen M. Niswender, J. Scott Daniels, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn	2014	33
18	Allosteric Modulators of Metabotropic Glutamate Receptor 5 for Treatment of Schizophrenia Research Portal (Queen's University Belfast) ·Shaun R. Stauffer, Jason Manka, Richard D. Williams, (unknown), Satyawan Jadhav, (unknown), Paige N. Vinson, Colleen M. Niswender, Jerri M. Rook, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn, Tasha N. Blatt, Emily Days	2011	1
19	Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function Molecular Pharmacology ·Meredith J. Noetzel, Jerri M. Rook, Paige N. Vinson, Hyekyung P. Cho, Emily Days, Ying Zhou, Alice L. Rodriguez, Hilde Lavreysen, Shaun R. Stauffer, Colleen M. Niswender, Zixiu Xiang, J. Scott Daniels, Carrie K. Jones, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn	2011	99
20	Morphine-induced early delays in wound closure: Involvement of sensory neuropeptides and modification of neurokinin receptor expression Biochemical Pharmacology ·Jerri M. Rook, Wohaib Hasan, Kenneth E. McCarson	2009	52

About Jerri M. Rook

Jerri M. Rook is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Equine, Biological Psychiatry and Developmental Neuroscience, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (40 papers), Neuroscience and Neuropharmacology Research (36 papers), Ion channel regulation and function (13 papers), Nicotinic Acetylcholine Receptors Study (10 papers), Pharmacological Receptor Mechanisms and Effects (6 papers), Neuropeptides and Animal Physiology (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Pediatric Pain Management Techniques (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.2k citations), Biological Psychiatry (62 citations), Molecular Biology (1.1k citations), Cognitive Neuroscience (198 citations) and Rehabilitation (46 citations). Jerri M. Rook has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Carrie K. Jones, Kenneth E. McCarson, Zixiu Xiang, Shaun R. Stauffer, Wohaib Hasan, Alice L. Rodriguez and J. Scott Daniels. Their work appears in journals such as ACS Chemical Neuroscience, Neuropsychopharmacology, Molecular Pharmacology, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact